Nupercainal Bio-active Hemorrhoidal
NDC Package 55741-424-24
Package Information
Nupercainal Bio-active Hemorrhoidal is adults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipegently dry by patting or blotting with a tissue or a soft cloth before insertion of this productdetach one suppository from the strip; remove the wrapper before inserting into the rectum as follows:hold suppository with rounded end upas shown, carefully separate tabs by inserting tip of fingernail at end marked "peel down"slowly and evenly peel apart (do not tear) by pulling tabs down both sides, to expose the suppositoryremove exposed suppository from wrapperinsert one suppository into rectum up to 4 times daily, especially at night, in the morning or after each bowel movementchildren under 12 years of age: ask a doctor. Marketed by Ducere Pharma, this product is identified by NDC 55741-424.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55741 - Ducere Pharma
- 55741-424 - Nupercainal Bio-active Hemorrhoidal
- 55741-424-24 - 4 BLISTER PACK in 1 CARTON / 6 SUPPOSITORY in 1 BLISTER PACK
- 55741-424 - Nupercainal Bio-active Hemorrhoidal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55741-424-24 identifies a specific commercial package of 4 blister pack in 1 carton / 6 suppository in 1 blister pack of Nupercainal Bio-active Hemorrhoidal, labeled by Ducere Pharma. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ducere Pharma on April 07, 2014. The current certification is valid through December 31, 2018.
How is this Ducere Pharma product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55741042424. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.